Apr 3, 2026Acquisition
Anthropic Acquires Coefficient Bio in $400M Deal
Anthropic's Strategic Move into HealthcareAnthropic, a company known for its advancements in AI, has made a significant move into the healthcare and life sciences sector with the acquisition of the stealth biotech AI startup, Coefficient Bio, in a $400 million stock deal. This news was first reported by The Information and Eric Newcomer, and sources close to the deal have confirmed its closure to TechCrunch, though the exact amount was not disclosed.Coefficient Bio's Background and ImpactCoefficient Bio, founded by Samuel Stanton and Nathan C. Frey, who both have a background in computational drug discovery at Genentech's Prescient Design, was launched eight months ago. The startup was utilizing AI to streamline drug discovery and biological research processes. With the acquisition, the team of around 10 members is expected to join Anthropic's health and life science team, bolstering their capabilities in this domain.Anthropic's Continued ExpansionThis acquisition follows Anthropic's announcement in October of Claude for Life Sciences, a tool designed to assist scientific researchers in making discoveries. The purchase of Coefficient Bio signifies a strategic expansion into healthcare and life sciences, indicating a commitment to leveraging AI for advancements in these fields.What This Means for the IndustryThe acquisition highlights the growing trend of AI companies venturing into biotech and healthcare, aiming to revolutionize drug discovery and research. It also underscores the value placed on AI-driven efficiency in these sectors, as companies look to accelerate scientific breakthroughs.
Feb 25, 2026Acquisition
Anthropic Acquires AI Startup Vercept to Enhance Claude Product
Anthropic, a company specializing in AI technology, has announced the acquisition of Vercept, a Seattle-based AI computer interface builder, for an undisclosed amount. This strategic move comes on the heels of Anthropic's unveiling of Claude Sonnet 4.6, its most advanced model yet for computer usage.Vercept's Background and AchievementsVercept was founded in 2024 by a team of former Allen Institute for AI (AI2) researchers, including Matt Deitke, Kiana Ehsani, Ross Girshick, Luca Weihs, and Oren Etzioni. The startup gained prominence after launching its flagship product, Vy, a cross-platform AI agent that allows users to control their computers using natural language for app navigation and content management. Vercept has successfully raised over $50 million in funding, including a $16 million round in January 2025, with notable investors such as Fifty Years VC founding partner Seth Bannon, Point Nine Capital, AI2 Incubator, and Madrona.Not all members of Vercept's founding team were in favor of the acquisition. Oren Etzioni expressed his disappointment on LinkedIn, stating that Vercept was 'throwing in the towel' and giving customers 30 days to migrate off the platform. Vy is scheduled to shut down on 25 March. Etzioni also criticized the startup's board, led by lead investor Seth Bannon and CEO Kiana Ehsani, for lacking product and business expertise.Despite the controversy, Anthropic continues to expand its offerings. Last December, Anthropic acquired Bun, a coding toolkit, to accelerate Claude Code. More recently, on 24 February, Anthropic partnered with DocuSign to integrate Claude Cowork, allowing DocuSign users to manage agreements using natural language prompts.What This Means for the AI IndustryThe acquisition of Vercept signifies Anthropic's commitment to enhancing its AI products and expanding its market presence. With the integration of Vercept's technology, Anthropic's Claude product is expected to see improvements in its agentic abilities, further solidifying Anthropic's position in the competitive AI landscape.
